Related Experiment Video
Updated: Sep 27, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations?
U Nowak-Göttl1, C Escuriola, K Kurnik
1Pediatric Hematology/Oncology, University of Münster, Albert-Schweitzer-Str. 33, 48149 Münster, Germany. leagottl@uni-muenster.de
Insights
Prothrombotic risk factors in children with severe hemophilia A (HA) influence clinical outcomes. Children with these factors experienced their first bleeding symptoms later, indicating a complex interplay between bleeding and clotting disorders.
Area of Science:
- Pediatric Hematology
- Thrombosis and Hemostasis
Background:
- Severe hemophilia A (HA) is a bleeding disorder.
- Prothrombotic risk factors are genetic and acquired conditions that increase the risk of blood clots.
Purpose of the Study:
- To investigate the prevalence of prothrombotic risk factors in pediatric patients with hemophilia A.
- To determine the impact of these risk factors on the clinical presentation and outcomes of severe HA in children.
Main Methods:
- A multicenter cohort study involving 135 pediatric patients with hemophilia.
- Analysis of factor VIII activity, factor V (FV) G1691A mutation, factor II (FII) G20210A variant, methylenetetrahydrofolate reductase (MTHFR) T677T genotype, elevated lipoprotein a (Lp a), antithrombin, protein C, and protein S.
- Comparison of the age of first symptomatic bleeding between children with and without prothrombotic risk factors.
Main Results:
- Prevalence of prothrombotic risk factors in severe HA patients was similar to general population data.
- Children with severe HA carrying prothrombotic risk factors had a later onset of first symptomatic bleeding (median 1.6 years) compared to non-carriers (median 0.9 years).
- Two cases of neonatal stroke with hemorrhagic transformation were observed in patients with elevated Lp a and FII GA variant.
- Catheter-related thrombosis occurred in 8 out of 25 children with central lines during Factor VIII concentrate administration.
Conclusions:
- The clinical phenotype of severe hemophilia A in childhood is influenced by the coinheritance of prothrombotic risk factors.
- Coinherited prothrombotic factors may modify the bleeding phenotype and increase the risk of thrombotic events in pediatric hemophilia A patients.
Unlabelled:
For the study presented here 135 pediatric PUP patients with haemophilia consecutively admitted to German pediatric haemophilia treatment centers were investigated. In addition to factor VIII activity, the factor V (FV) G1691A mutation, the factor II (FII) G20210A variant, methylenetetrahydrofolate reductase (MTHFR) T677T genotype, elevated lipoprotein a (Lp a), antithrombin, protein C, and protein S were investigated. 103 out of 122 HA patients (FVIII activity <1%) were suffering from severe HA. The prevalence of prothrombotic risk factors in children with severe haemophilia A (HA) did not differ from previously reported data: FV GA 5.8%, FII GA 3.9%, MTHFR TT 10%, elevated Lp a 7%, protein C type I deficiency 1.1%. The first symptomatic bleeding leading to diagnosis of severe haemophilia occurred with a median age of 1.6 years (range: 0.5-7.1 years) in children carrying prothrombotic risk factors compared to non-carriers (0.9 years (0.1-4.0; p = 0.01). Two patients presenting with neonatal stroke due to elevated Lp a and the FII GA variant showed haemorrhagic stroke transformation triggered by severe haemophilia. In addition, when haemophilia A was corrected by administration of factor VIII concentrates eight out of 25 children with central lines in place developed catheter-related thrombosis.
Conclusion:
The data of this multicentre cohort study demonstrate that the clinical phenotype of severe haemophilia A in childhood is clearly influenced by the coinheritance of prothrombotic risk factors.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pedigree Analysis
Multiple Allele Traits
Multiple Allele Traits
X-linked Traits
